Nomura Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Nomura Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-555,000	Closed	-$16.7M	–	2045
2026 Q1	$16.7M	Sell	555,000 -599,100	-52%	-$19.3M	0.04%	294
2025 Q4	$36M	Buy	1,154,100 +1,023,900	+786%	+$25.2M	0.05%	202
2025 Q3	$2.63M	Sell	130,200 -5,239,600	-98%	-$92M	﹤0.01%	1037
2025 Q2	$90M	Buy	+5,369,800	New	+$86.7M	0.19%	79
2025 Q1	–	Sell	-1,961,500	Closed	-$43.2M	–	2360
2024 Q4	$43.2M	Buy	+1,961,500	New	+$35.7M	0.06%	180
2023 Q4	–	Sell	-2,727,500	Closed	-$27.8M	–	1970
2023 Q3	$27.8M	Buy	+2,727,500	New	+$25.4M	0.08%	172
2022 Q4	–	Sell	-5,000	Closed	-$40K	–	1708
2022 Q3	$40K	Hold	5,000	–	–	﹤0.01%	1398
2022 Q2	$40K	Hold	5,000	–	–	﹤0.01%	1515
2022 Q1	$47K	Buy	+5,000	New	+$41.7K	﹤0.01%	1765
2021 Q1	–	Sell	-100,000	Closed	-$960K	–	2271
2020 Q4	$960K	Buy	+100,000	New	+$958K	﹤0.01%	1051
2018 Q3	–	Sell	-27,000	Closed	-$512K	–	1499
2018 Q2	$512K	Buy	+27,000	New	+$551K	﹤0.01%	996
2017 Q4	–	Sell	-340,000	Closed	-$5.98M	–	1673
2017 Q3	$5.98M	Buy	340,000 +40,000	+13%	+$900K	0.01%	498
2017 Q2	$9.96M	Hold	300,000	–	–	0.02%	372
2017 Q1	$9.63M	Sell	300,000 -371,700	-55%	-$12.7M	0.03%	315
2016 Q4	$24.3M	Sell	671,700 -1,560,600	-70%	-$62.3M	0.06%	192
2016 Q3	$103M	Buy	2,232,300 +982,300	+79%	+$51.3M	0.29%	56
2016 Q2	$62.8M	Buy	+1,250,000	New	+$66.5M	0.21%	54
2015 Q3	–	Sell	-1,505,000	Closed	-$76M	–	1950
2015 Q2	$76M	Buy	+1,505,000	New	+$92.8M	0.21%	55
2015 Q1	–	Sell	-2,706,300	Closed	-$137M	–	2248
2014 Q4	$137M	Buy	2,706,300 +236,300	+10%	+$13.2M	0.37%	39
2014 Q3	$125M	Buy	2,470,000 +320,000	+15%	+$17M	0.34%	56
2014 Q2	$113M	Sell	2,150,000 -274,000	-11%	-$14M	0.03%	80
2014 Q1	$127M	Buy	+2,424,000	New	+$112M	0.04%	65

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Nomura Holdings's TEVA Position: Q2 2026 in Review

Nomura Holdings reduced its Teva Pharmaceuticals (TEVA) stake by 52% in Q2 2026, selling an estimated $40.4M and leaving 1,124,772 shares worth $38.1M. The position accounts for 0.04% of the portfolio, ranked #232.

Nomura Holdings first reported a position in TEVA in Q2 2013 and has held it in 43 quarters since. The position peaked at $75.9M in Q3 2014. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Nomura Holdings held 1,124,772 shares of Teva Pharmaceuticals worth $38.1M as of Q2 2026.
Nomura Holdings sold 1,213,830 Teva Pharmaceuticals shares in Q2 2026, an estimated $40.4M.
Teva Pharmaceuticals made up 0.04% of Nomura Holdings's portfolio in Q2 2026, its #232 holding.
Nomura Holdings first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 43 quarters since.
Nomura Holdings's Teva Pharmaceuticals position peaked at $75.9M in Q3 2014.
676 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.